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Hypokalaemia and its subsequent complications are more often seen in children rather than in adults and are more
common with falciparum malaria. This is a case of a 26-year-old male with Plasmodium vivax malaria who had
developed paraparesis secondary to hypokalaemia. His treatment involved correction of the potassium level as well as
the treatment of malaria. Such an atypical manifestation of malaria in an adult has not been previously documented.
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A 26-year-old male presented at the hospital with com-
plaints of high grade intermittent fever, with chills, for two
days and the sudden onset of progressive weakness for a
day. The fever was not accompanied by vomiting, diarrhoea
or any other systemic complaints. The patient had been
treated by a local doctor after his complete blood count
screen had revealed Plasmodium vivax malaria (trophozo-
ites in blood smear) with thrombocytopenia (platelets
56,000/mm3). He had been given cefixime 200mg po bid
and artesunate 200mg po od for a day. The next day, he
had suddenly developed gradually progressive lower limb
weakness leading to an inability to stand up and walk. He
denied any history of recent vaccinations, use of diuretics,
any trauma or seizures. There was neither any history of a
similar weakness in his past nor any family history of it.
The patient denied any history of alcohol, tobacco or recre-
ational drug use. A driver by occupation, he lived in an
urban area. He denied any prior history of malaria.
On physical examination, his pulse was 74/min, regular;
his blood pressure was 124/70 mm Hg and his abdominal
examination revealed mild splenomegaly. His cardiac
examination was unremarkable. The neurological examin-
ation showed bilateral lower limb flaccid paralysis (grade I
power) with knee and ankle reflexes absent, with absent
bilateral plantar reflexes. In the lower limbs, the muscle
tone was reduced without any muscle tenderness. Lower
limb sensations were intact. The power was 5/5 in upper* Correspondence: drsagarsinha@gmail.com
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reproduction in any medium, provided the orlimbs with no sensory deficit. The cranial nerves examin-
ation was normal. The patient was admitted to the hos-
pital and his blood samples were sent for urgent tests for
serum electrolytes. The results revealed a potassium value
of 1.47 mEq/L. The ECG, correspondingly, showed flat-
tened T waves and the presence of U waves.
Intravenous potassium chloride was given for correcting
the potassium level and, since it was a life-threatening
hypokalaemia (<1.5 mEq/L), at a relatively rapid rate of 30
mEqs/hr. Repeat serum chemistry after three hours showed
a potassium value of 2.67 mEq/L. There was some im-
provement in clinical signs of weakness and ECG. The rate
of correction was subsequently slowed down to 20mEqs/
hr. After a total infusion of 150 mEqs potassium IV, elec-
trolyte tests repeated after 8 hours, showed a potassium
value of 5.25 mEq/L. Potassium supplementation was then
stopped. The correlation of the potassium value with the
neurological examination and ECG is given in Table 1, also
indicating the moments when potassium supplementation
was carried out. The patient did not have any complaints
after 8 hours of hospitalization. The repeat electrolytes tests
done on the subsequent days revealed potassium in the
normal range. The correlation of the potassium value with
the lower limb neurological examination findings over the
course of hospitalization is given in Figure 1.
Arterial blood gas, serum magnesium, serum calcium,
blood sugar and renal function were within normal limits.
The liver function tests showed mild indirect bilirubinemia.
His urine test results were within the normal range. The
patient also tested negative for dengue, leptospirosis and
HIV. Total T4 was mildly elevated; however, TSH andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 The correlation of the potassium value with the neurological examination and ECG
Time Day 1–0 hours Day 1–3 hours Day 1–8 hours Day 2/3/4
Potassium (mEq/L) 1.47 2.67 5.25 4.74/4.23//4.33
Potassium Supplementation Started at 30 mEqs/hr
for 3 hours
Continued at 20 mEqs/hr
for 3 hours
Stopped -
Total mEqs supplemented 0 90 150 -
ECG Flattened T waves,
U waves present
Flattened T waves present,
U waves absent
Normal Normal
Upper Limbs- Tone Normal Normal Normal Normal
Upper Limbs- Power 5/5 5/5 5/5 5/5
Upper Limbs- Reflexes Normal (2+) Normal (2+) Normal (2+) Normal (2+)
Upper Limbs- Sensory Normal Normal Normal Normal
Lower Limbs- Sensory Normal Normal Normal Normal
Lower Limbs- Tone Hypotonia (flaccid) Normal Normal Normal
Lower Limbs- Power 1/5 4/5 5/5 5/5
Lower Limbs- Reflexes (Knee and Ankle) Absent (0) Present (1+) Present (2+), normal Present (2+), normal
Plantar Reflex Absent Absent Normal flexor response Normal flexor response
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gations is given in Table 2.
The patient received artesunate 120mg IV 12 hourly on
day 1 followed by od dose for two days, ceftriaxone 1gm
IV 12 hourly for three days and doxycycline 100mg po
bid for five days. Injectibles were stopped on day 4 and he
was put on artemether/lumefantrine 80/480mg po bid for
three days; and to prevent a relapse, primaquine 7.5mg po
bid was added for fourteen days after testing for glucose-
6-phosphate dehydrogenase deficiency.
The patient was discharged home on day 5. He returned
for a follow-up consultation two weeks later. He did not
have any complaints, including fever, during that interven-
ing period.
Discussion
Around 1.5 million confirmed cases of malaria are
reported from India annually. The current national pol-
icy recommends artemisinin combination therapy for
falciparum cases and chloroquine plus primaquine forFigure 1 Correlation of the potassium value with the lower limb neurvivax cases. Oral artemisinin monotherapy is banned in
India to prevent resistance. However, the policy also rec-
ommends prompt treatment of severe malaria with par-
enteral artemisinin derivatives or quinine [1]. In the
region of greater Mumbai, malaria has a high prevalence
of more than 1 case per 1,000 population [2]. Resistance
to chloroquine has been steadily rising in this region as
well [3]. As a result, across the region, for treatment of
even vivax cases, artemisinin combination therapy has
become quite popular, with an addition of doxycycline
or clindamycin.
Dworak et al. stated that there was a progressive decrease
in the sodium and potassium levels within 12 hrs of the
parasite’s entry into the host [4]. Hypokalaemia in malaria
has been observed in falciparum cases in children, where
the underlying cause was proposed to be the correction of
acidosis seen usually in severe cases of malaria [5]. A study
from Gujarat, India, found hyponatremia and hypokalaemia
to be more common in falciparum than vivax malaria [6].
Another study from Nigeria showed significantly loweredological examination findings over the course of hospitalization.
Table 2 Summary of haematology results
Units Reference range Pre-admission Day 1 Day 2 Day 3 Day 4
Haemoglobin gm/dL 11-18 11.5 11.1 10.8 11.4
Total Leukocyte Count K/uL 4-10 7.9 8.1 5.5 6.4
Platelet Count /uL 150,000-400,000 56,000 76,000 31,000 179,000








Glucose-6-Phosphate Dehydrogenase no deficiency seen
0 hrs 3 hrs 8 hrs
Serum Electrolytes mEq/L Sodium: 135-148 141 141 143 140 138 139
Potassium: 3.7-5.3 1.47 2.67 5.25 4.74 4.23 4.33
Chloride: 100-108 110 110 109 107 107 107
Serum Calcium mg/dL 8.5-10.1 9.2 9.4
Serum Magnesium mg/dL 1.7-2.3 2.3 2.1
Serum Creatinine mg/dL 0.6-1.3 0.8 0.8
Blood Urea Nitrogen mg/dL 7-18 11 12
Bilirubin mg/dL Total: 0-1 1.5
Direct: 0–0.3 0.2
Indirect: 0–0.7 1.3
Arterial Blood Gas Normal
HIV ELISA Non-Reactive
Leptospirosis Antibody IgM Negative
Dengue Rapid NS-1 Antigen Negative
IgM Antibody Negative
IgG Antibody Negative
Thyroid Profile mcg/dL TSH: 0.4-5.3 4.94
Total T3: 69-205 129.97
Total T4: 4.5-12.6 13.7
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their analysis, Thanachartwet et al. found a high prevalence
of hypokalaemia in Thai patients with malaria, and signifi-
cant association of hypokalaemia with vivax infection,
hyponatraemia and hypovolaemia. They postulated that the
hypokalaemia was multifactorial, from a combination of
intracellular translocation of potassium from extracellular
fluid and urinary potassium loss [8].
Case reports have been published concerning motor
weakness secondary to hypokalaemia in other infectious
diseases in adults, namely chikungunya [9], dengue fever
[10] and leptospirosis [11]. Periodic paralysis has also been
reported in malaria wherein the combination of transient
hyperkalaemia and rigors occurring during febrile episodes
of malaria has been suggested as the underlying cause
which precipitating muscular paralysis [12]. Although mal-
aria has been found to be associated with various neuro-
logical and psychiatric complications, and neurological
manifestations to anti-malarial drugs have been docu-
mented [13]; the authors could not find any literature
documenting the association of such a type of motor weak-
ness (hypokalaemic) with malaria.
There have been case reports of malaria causing Guillian
Barre Syndrome [14,15], but since the patient’s recovery
from the paraparesis was dramatic and complete within a
few hours of potassium supplementation, it was easily ex-
cluded from the differential diagnosis and neither the
EMG/NCV studies nor a lumbar puncture (for CSF ana-
lysis) was performed. Since the patient had only lower
limb muscle weakness, without the involvement of any
higher functions or cranial nerves and in the absence of
upper motor neuron signs, MRI was not performed.
There was no obvious fluid loss since there was no
report of vomiting or diarrhoea or any altered urine
output. Increased catecholamine levels in response to
stress of the infection and secondary insulin release may
result in intracellular shift of potassium and hypokalae-
mia. Hyperventilation due to hyperpyrexia and respira-
tory alkalosis has also been suggested as a cause for
hypokalaemia [16].
The patient’s magnesium levels were normal and T4
was mildly elevated. There was no strenuous exercise pre-
ceding the weakness thereby ruling out any glycogen stor-
age disorder. Also, since there was no similar episode of
weakness in the past or any family history of it, familial
channelopathies were not included in the differential diag-
nosis and got no further workup.
Also, artemisinins can potentially cause hypokalaemia.
They have been known to affect voltage-gated potassium
currents, and their administration in patients of hypokal-
aemia has been known to prolong the QT-interval. Hara
et al. examined the effect of artemisinins on ligand-
gated potassium currents and found an inhibitory effect
[17]. Development of immunity, increasing resistance toantimalarial drugs and indiscriminate use of anti-
malarial drugs have also been proposed as the causes for
malaria presenting with unusual features in endemic
areas [18].
The authors believe that in this case the patient devel-
oped hypokalaemia most likely due to a distributional shift
of potassium, which was potentiated by the drugs he re-
ceived before his hospitalization. However, he did not have
any similar response to the artemisinins after admission
(artesunate IV) and after discharge (artemether po).
Conclusion
Physicians, especially those in endemic areas of malaria,
must consider motor weakness being caused by compli-
cations secondary to infectious diseases, especially a
prevalent one like malaria. Potassium levels must be
monitored in a case presenting with such symptoms.
Once the presence of hypokalaemia in a case has
been established, the authors recommend the following
approach:
– to determine its cause
– to fully evaluate and investigate the patient
– to treat the hypokalaemia (aggressively, if life-
threatening) and its complications
– to treat the malaria
– to treat the underlying cause/trigger of the
hypokalaemia.
A thorough neurological examination must be done to
determine the extent of the weakness and its type
(whether flaccid or spastic) and associated features. An
ECG must be quickly obtained as well. The patient’s
fluid status must be evaluated to rule out hypovolaemia
and urine output must be monitored. Arterial blood gas
should be tested to evaluate alkalosis, anion gap and bi-
carbonate levels. Magnesium and calcium deficiency
must also be ruled out. Persistent weakness despite po-
tassium correction and normalization of its values could
warrant EMG/NCV, imaging and CSF tests. Thyroid
profile should also be done to exclude periodic paralysis.
From the existing literature, it is clear that hypo-
kalaemia and hyponatremia are now well documented
phenomena in malaria patients. However, the actual in-
cidence of hypokalaemia and its associated clinical ma-
nifestations may be highly underestimated. Further
studies are required to determine its epidemiology and
pathophysiology.
Patient’s consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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